MedTrace Logo

Genomics and Metagenomics of Asthma Severity

NCT04501926 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-05-17

No results posted yet for this study

Summary

The Genomics and Metagenomics of Asthma Severity (GEMAS) study aims to assess the role of genomics, the microbiome, and the interaction between them in the development of asthma exacerbations in European patients with asthma.

Conditions

Sponsors & Collaborators

  • University of La Laguna

    collaborator OTHER

  • Ministry of Science and Innovation, Spain

    collaborator OTHER_GOV

  • Consorcio Centro de Investigación Biomédica en Red (CIBER)

    collaborator OTHER_GOV

  • University Hospital of the Nuestra Señora de Candelaria

    collaborator OTHER

  • Hospital Universitario de Canarias

    collaborator OTHER

  • Hospital General de La Palma

    collaborator UNKNOWN

  • Hospital Donostia

    collaborator OTHER

  • Hospital Doctor Jose Molina Orosa

    collaborator UNKNOWN

  • Maria Pino-Yanes

    lead OTHER

Eligibility

Min Age
8 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04501926 on ClinicalTrials.gov